Showing results (161-170 of 552) with videos related to
Sort By:
Pageof 56
Biological Psychiatry|May 15, 1993
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjectsN Wodarz, J Fritze, P Riederer, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissueJ Kornhuber, B Herr, J Thome, et al.Journal of Neural Transmission. Supplementum|August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's diseaseM Gerlach, K Double, H Reichmann, et al.Journal of Neural Transmission. Supplementum|January 1, 1992
Neurotoxicity and neuroprotection in Parkinson's diseaseK W Lange, M B Youdim, P RiedererClinical Pharmacology and Therapeutics|December 1, 1994
Biochemical actions of l-deprenyl (selegiline)K W Lange, P Riederer, M B YoudimBiological Psychiatry|February 1, 1992
3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspectsN Wodarz, J Fritze, J Kornhuber, et al.Journal of Neural Transmission. Supplementum|January 1, 1994
Amantadine and memantine are NMDA receptor antagonists with neuroprotective propertiesJ Kornhuber, M Weller, K Schoppmeyer, et al.European Journal of Pharmacology|May 11, 1989
Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitorsJ Fritze, P Koronakis, C Konradi, et al.Psychopathology|January 1, 1987
Biochemical aspects of dysphoria: case study for hypothesis generationP Kruzik, E Sofic, P Riederer, et al.Journal of Neural Transmission. Supplementum|December 16, 1998
Free radicals in Alzheimer's dementia: currently available therapeutic strategiesM Rösler, W Retz, J Thome, et al.Pageof 56